These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

688 related items for PubMed ID: 20489418

  • 1. The global burden of diabetes and its complications: an emerging pandemic.
    van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B.
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S3-8. PubMed ID: 20489418
    [Abstract] [Full Text] [Related]

  • 2. [Type-2 diabetes mellitus as a cause of disability].
    Piechota G, Małkiewicz J, Karwat ID.
    Przegl Epidemiol; 2004 May; 58(4):677-82. PubMed ID: 15810510
    [Abstract] [Full Text] [Related]

  • 3. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.
    Davis WA, Knuiman MW, Hendrie D, Davis TM.
    Intern Med J; 2006 Mar; 36(3):155-61. PubMed ID: 16503950
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and incidence of Type 2 diabetes and its complications 1996-2003--estimates from a Swedish population-based study.
    Ringborg A, Lindgren P, Martinell M, Yin DD, Schön S, Stålhammar J.
    Diabet Med; 2008 Oct; 25(10):1178-86. PubMed ID: 19046196
    [Abstract] [Full Text] [Related]

  • 5. Socio-economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain.
    Larrañaga I, Arteagoitia JM, Rodriguez JL, Gonzalez F, Esnaola S, Piniés JA, Sentinel Practice Network of the Basque Country.
    Diabet Med; 2005 Aug; 22(8):1047-53. PubMed ID: 16026371
    [Abstract] [Full Text] [Related]

  • 6. Early onset type 2 diabetes mellitus: a harbinger for complications in later years--clinical observation from a secondary care cohort.
    Song SH, Hardisty CA.
    QJM; 2009 Nov; 102(11):799-806. PubMed ID: 19734298
    [Abstract] [Full Text] [Related]

  • 7. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS, Al-Suwaida A, Isnani AC, Al-Harbi A, Alam A.
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [Abstract] [Full Text] [Related]

  • 8. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB.
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [Abstract] [Full Text] [Related]

  • 9. [Epidemiological features of diabetes-related complications].
    Simon D, Coutant R.
    Rev Prat; 2007 Sep 15; 57(13):1411-22. PubMed ID: 18018540
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The Swedish cost burden of overweight and obesity--evaluated with the PAR approach and a statistical modelling approach.
    Odegaard K, Borg S, Persson U, Svensson M.
    Int J Pediatr Obes; 2008 Sep 15; 3 Suppl 1():51-7. PubMed ID: 18278633
    [Abstract] [Full Text] [Related]

  • 12. Diabetes in Japan: a review of disease burden and approaches to treatment.
    Neville SE, Boye KS, Montgomery WS, Iwamoto K, Okamura M, Hayes RP.
    Diabetes Metab Res Rev; 2009 Nov 15; 25(8):705-16. PubMed ID: 19795421
    [Abstract] [Full Text] [Related]

  • 13. [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].
    Köhler C, Temelkova-Kurktschiev T, Schaper F, Fücker K, Hanefeld M.
    Dtsch Med Wochenschr; 1999 Sep 17; 124(37):1057-61. PubMed ID: 10520305
    [Abstract] [Full Text] [Related]

  • 14. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W, Majkowska L, Stefański A, Moleda P.
    Przegl Lek; 2005 Sep 17; 62(4):201-5. PubMed ID: 16229234
    [Abstract] [Full Text] [Related]

  • 15. The economic burden of insulin resistance.
    Turtle JR.
    Int J Clin Pract Suppl; 2000 Oct 17; (113):23-8. PubMed ID: 11965827
    [Abstract] [Full Text] [Related]

  • 16. The cost of treating type 2 diabetes (CODEIRE).
    Nolan JJ, O'Halloran D, McKenna TJ, Firth R, Redmond S.
    Ir Med J; 2006 Oct 17; 99(10):307-10. PubMed ID: 17274175
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The burden of diabetes and its complications: trends and implications for intervention.
    Chaturvedi N.
    Diabetes Res Clin Pract; 2007 May 17; 76 Suppl 1():S3-12. PubMed ID: 17343954
    [Abstract] [Full Text] [Related]

  • 19. The global impact of noncommunicable diseases: estimates and projections.
    Manton KG.
    World Health Stat Q; 1988 May 17; 41(3-4):255-66. PubMed ID: 3232413
    [Abstract] [Full Text] [Related]

  • 20. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD, Gillett M, Holmes M, Ogden E.
    Public Health; 2006 Dec 17; 120(12):1140-8. PubMed ID: 17084425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.